Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Contract Research Organization providing Phase I-IV core development 
services for drug, biologic, and device programs
News and Upcoming Events

Find out how our clinical research expertise in drug and medical device can help with your next study or program.


PDF: Medpace Fact Sheet

News Releases


Medpace Announces Participation in “Rare Disease Day” on February 28th 2017


Medpace is Proud to Present Four Scientific Posters at AAPS This Year

Medpace Holdings, Inc. Reports Third Quarter 2016 Results

Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference

Medpace Presentation at ISPOR: Design and Operational Considerations for Hybrid Retrospective-Prospective Studies

Medpace Holdings, Inc. to Report Third Quarter 2016 Financial Results on November 3, 2016

Medpace Hosts Oncology Trial Recruitment Webinar on November 8th

Medpace Announced as Finalist for Annual Society for Clinical Research Sites’ Eagle Award

Medpace Hosts Complimentary Webinar on Advanced Therapy

Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences

Four Medical Directors Join Medpace’s Therapeutically-focused Teams

Medpace Holdings, Inc. Announces Closing of Initial Public Offering

Medpace Holdings, Inc. Announces Pricing of Initial Public Offering

Medpace Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering

Medpace and IHMA Announce Strategic Alliance to Provide Microbiology Laboratory Services for Clinical Studies

Medpace Experts Presenting at the DIA 2016 Annual Meeting in Philadelphia June 26-30

Dr. Blythe Thomson Joins Medpace as Senior Medical Director

Medpace is now a Global Impact Partner at Society for Clinical Research (SCRS)

New Webinar: Latin America - Challenges & Opportunities in Clinical Research

Medpace Hosting Medical Device Lunch and Learn Workshops in Boston and San Francisco

Medpace QA to Present at Annual SQA Meeting

Medpace’s Newest Infectious Diseases and Vaccines Expert to Attend World Vaccine Congress

Actinium Pharmaceuticals Selects Medpace Inc. as Clinical Research Organization for Pivotal Phase 3 Iomab-B Trial

Medpace Provides Full Service Support for Anamorelin Phase III Study – Download Article Published in Lancet Oncol 2016

Medpace’s Paul Travis, BSc, MSc, Authors Article on Biomarker Advances in Central Labs

Medpace Hosts Immuno-Oncology Webinar on March 9th

Medpace Announces Participation in “Rare Disease Day” on February 29th 2016

Medpace Experts Presenting at SCOPE Summit For Clinical Operations Executives: Tracks Include Managing Biomarker-Driven Trials and Managing Late Stage Research and Observational Studies

Medpace Presenting at Outsourcing in Clinical Trials West Coast 2016: “Special Considerations for Managing Immuno-Oncology Studies – A New Paradigm”


Medpace Announces Wrap-Up of "The Power of Giving Campaign"

Traci Turner, MD; and Evan A. Stein, MD, PhD of MARC publish new article, Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes.

Medpace Continues to Expand Global Infectious Disease and Vaccine Drug Development Capabilities; Prasad Velisetty M.D. Joins Medpace as Senior Medical Director, Medical Affairs

Medpace’s Andrew Masih, London-based Senior Director of Clinical Operations, on how CROs are taking over from big pharma as training ground for the life sciences industry

Dr. Glynis Neagle Joins Medpace as Vice President, Medical Affairs

Medpace recognized as a member of the Deloitte Cincinnati USA 100 for the 8th consecutive year

David G. Orloff, MD, Senior Vice President, Medical and Regulatory Affairs Dies after a Prolonged Illness

Medpace Continues Growth in Europe with Expanded Facilities in Stirling, United Kingdom

Upcoming Live Webinar: August 26, Pharmacoeconomic Assessment through Market Approval and Beyond: Theory and Operations

Medpace Expands Leadership for Endocrinology Team Phillippa Miranda, MD Joins Medpace as Sr. Director, Medical Affairs

Medpace Named a Top Cincinnati Workplace for 2015 by the Cincinnati Enquirer

Dr. August Troendle, an EY Entrepreneur Of The Year Award Winner

Medpace Experts Presenting at DIA on Rare Disease Clinical Development and Pharmacovigilance

Medpace Continues “The Power of Giving” Campaign at ASCO

Medpace Adds Geriatric Psychiatrist to Expanding Team of Physicians in Neuroscience Drug Development

Dr. Franklin O. Smith Presenting on Precision Medicine at Outsourcing in Clinical Trials East Coast

Malcolm McIntyre to Present Central Lab Innovation in Patient Centric Clinical Trials at Outsourcing in Clinical Trials - Europe

Mark Metzner and Dr. Charles Pierce to Present Best Practices in Patient Recruitment at ACRP

Medpace Expands Leadership in Early Phase and Neuroscience Drug Development - Dr. Richard D. Scheyer Joins Medpace as Vice President Medical Affairs

Eric Humes to speak at the 31st SQA Annual Quality Meeting on the Cost of Non-Compliance in Clinical Studies

Medpace named Top Ten CRO in 2015 CenterWatch Investigative Site Survey

Medpace VP of Regulatory Affairs, Dr. Steven B. Johnson to present at Partnerships in Clinical Trials

Medpace Medical Device Hosting Workshops as Part of its Complex Medical Devices Series

Medpace Launches “The Power of Giving” Campaign - Program aligns with therapeutically-focused clinical research model

Dr. Franklin O. Smith Keynote Speaker at Leukemia and Lymphoma Society Program: “No Progress without Clinical Trials”

Dr. Evan Stein to Present on PCSK9 Inhibitors at ASCPT

Medpace to Present on Risk-Based Monitoring at Upcoming SCOPE Meeting

Medpace's Michelle Petersen to present on Rare Disease Study Conduct at Outsourcing in Clinical Trials West Coast

Medpace Supports Madisonville Revitalization

Dr. James J. Vornov Joins Medpace as Vice President, Medical Affairs

Dr. Markus Heep Joins Medpace as Medical Director for Infectious Disease


Medpace to Present Webinar - Understanding Real World Evidence: A Registry Study Perspective

Medpace Hosting Workshops: Connecting the Dots for Accelerated Rare Disease Studies

Dr. Anibal Ruben Calmaggi Joins Medpace as Senior Medical Director for Infectious Disease

Medpace Hosting Medical Device Workshops to Provide Best Practices for Conducting Global Trials

Medpace Salutes Julie J. Hopkins, Cincinnati Leukemia & Lymphoma Society Woman of the Year 2014

Medpace expands therapeutic leadership in Oncology with the addition of Franklin O. Smith, III, MD, as Vice President, Medical Affairs

Medpace expands offices in the UK, supporting rapid growth in European Clinical Teams

David Klein, MD, PhD joins Medpace as a Medical Director, Further Strengthening Global Endocrinology and Pediatric Drug Development Capabilities

Medpace Quality Assurance Executive Joins Industry Experts to conduct DIA Training in Beijing

Medpace Reference Laboratories (MRL) opens central laboratory in Singapore

Medpace Strengthens Cardiovascular, Pediatric, and Rare Disease Drug and Medical Device Development Capabilities: Dr. Pirouz Shamszad MD, FAAP joins Medpace as a Medical Director

NephroGenex picks Medpace for kidney disease Phase III

Medpace to Present at Partnerships in Clinical Trials 2014: Argos Therapeutics and Medpace present lessons learned from an oncology rescue study

Cinven invests in Medpace, citing strong growth drivers in the CRO market

Medpace to Present at Outsourcing Clinical Trials – West Coast

Medpace Strengthens Global Oncology Drug Development Capabilities - Dr. Jamal Gasmi joins Medpace as Medical Director

Cardiac Safety Research Consortium (CSRC) Releases Cardiovascular Case Report Forms for use in Non Cardiovascular Clinical Trials